Unilever PLC UL

Consumer StaplesPersonal & Household Products & ServicesUnited Kingdom

Last close 65.26 USD on Nov 1, 2026, +2.4% year to date

Quant rating

Quant rating C Rank 77 of 174 in Consumer Staples

Growth D 128 of 174
Valuation C 99 of 174
Quality B 68 of 174
Revisions C 92 of 174
Momentum B 49 of 174

Wall Street consensus Buy (1.83)Average target 76.79 USD +17.7%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Key data

Market cap: 140.3B
Enterprise value: 172.3B
52-week range: 54.75 – 74.97
3-year range: 49.78 – 74.97
Dividend yield: 3.30%
Beta (5 years): 0.43
Shares outstanding: 2,154M
Next earnings: Oct 26, 2026

About the company

Unilever PLC is a United Kingdom-based global consumer goods business. The Company's segments include Beauty & Wellbeing, Personal Care, Home Care and Foods. The Beauty & Wellbeing segment primarily sells hair care (shampoo, conditioner, styling), skin care (face, hand and body moisturizers) and includes Prestige Beauty and Wellbeing. The Personal Care segment primarily sells skin cleansing (soap, shower), deodorant and oral care (toothpaste, toothbrush, mouthwash) products. The Home Care segment primarily sells fabric care (washing powders and liquids, rinse conditioners) and a range of home and hygiene cleaning products. The Foods segment primarily sells cooking aids and mini-meals (soups, bouillons, seasonings), condiments (mayonnaise, ketchup) and Unilever Food Solutions. The Company's beauty & wellbeing brands include CLEAR, Dermalogica, Liquid I.V., Dove and TRESemme. The Company's home care brands include Cif, Comfort, Domestos, OMO, Radiant, Sunlight and Surf.

Growth and profitability fiscal year ends December 31

Growth and profitability by fiscal year
	2025	2024	2023	2022	2021	5Y avg
Revenue (mil)	59,316	54,332	65,779	64,290	59,618	–
Revenue growth	9.2%	−17.4%	2.3%	7.8%	−3.8%	−0.9%
EPS (basic, normalized)	3.47	3.63	3.16	3.04	3.48	–
EPS growth	−4.2%	14.7%	4.1%	−12.8%	–	–
Gross margin	46.9%	46.7%	42.2%	40.2%	42.3%	43.7%
Net margin	11.2%	10.3%	10.9%	12.7%	11.5%	11.3%
ROE	31.9%	28.4%	34.9%	42.3%	37.4%	35.0%

Balance sheet, last quarter
Cash & short-term investments (mil)	–
Current ratio	–
Long-term debt (mil)	–
Net debt (mil)	–
Total equity (mil)	–
Net debt / equity	–
Net debt / EBITDA	–

Estimates and valuation

Consensus estimates and implied multiples
	Sales (mil)			EBITDA (mil)			EPS
Fiscal year	Mean est.	Growth	EV/Sales	Mean est.	Growth	EV/EBITDA	Mean est.	Growth	P/E
2025 actual	59,316	+9.2%	2.9x	12,851	−1.8%	13.4x	3.47	−4.2%	18.8x
2026	58,462	−1.4%	2.9x	13,347	+3.9%	12.9x	3.61	+3.9%	18.1x
2027	58,236	−0.4%	3.0x	13,150	−1.5%	13.1x	3.68	+2.0%	17.7x
2028	57,779	−0.8%	3.0x	13,149	0.0%	13.1x	3.75	+1.7%	17.4x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
	Sales				EPS
Fiscal year	Estimate (mil)	1M	3M	6M	Estimate	1M	3M	6M
2026	58,462	−1.0%	−1.0%	−3.6%	3.61	−1.3%	−1.2%	−1.1%
2027	58,236	−0.8%	+0.3%	−2.9%	3.68	−1.1%	−0.8%	−1.6%
2028	57,779	+3.2%	+3.8%	+3.4%	3.75	−1.1%	−0.7%	−1.3%

Earnings surprises

Reported results versus consensus, last 10 fiscal quarters
	FQ-9	FQ-8	FQ-7	FQ-6	FQ-5	FQ-4	FQ-3	FQ-2	FQ-1	FQ0
Sales reported (mil)	–	–	–	–	–	–	–	–	–	–
Sales mean (mil)	–	–	–	–	–	–	–	–	–	–
Surprise	–	–	–	–	–	–	–	–	–	–
EPS reported	–	–	–	–	–	–	–	–	–	–
EPS mean	–	–	–	–	–	–	–	–	–	–
Surprise	–	–	–	–	–	–	–	–	–	–

FQ0 is the most recent reported quarter, FQ-1 the one before, and so on.

Peer comparison Personal & Household Products & Services

Peers in the same industry group, by market capitalization
Company	Market cap	Net debt/EBITDA	Net margin	P/B	FY1 P/E	FY2 P/E	FY1 EV/EBITDA	FY2 EV/EBITDA
UL Unilever PLC	140.3B	–	11.2%	8.21x	18.1x	17.7x	12.9x	13.1x
PG The Procter & Gamble Company	374.5B	1.04x	18.1%	6.80x	23.1x	21.8x	16.2x	15.4x
OREP L'Oreal SA	260.5B	–	13.9%	6.87x	31.7x	28.8x	21.3x	19.7x
CL Colgate-Palmolive Company	76.0B	1.35x	10.5%	321.88x	24.6x	23.3x	16.2x	15.5x
EL Estee Lauder Companies Inc	39.6B	1.53x	1.6%	10.38x	32.8x	27.3x	15.2x	13.4x
RKT Reckitt Benckiser Group PLC	45.8B	–	22.5%	6.06x	15.9x	15.2x	11.9x	11.3x
Mean		1.31x	13.0%	60.03x	24.4x	22.4x	15.6x	14.7x
Median		1.35x	12.6%	7.54x	23.8x	22.6x	15.7x	14.4x

Technical analysis

1M+4.4%
3M−1.6%
1Y+1.8%
3Y+45.8%

Financial statements in millions of USD

Income statement in millions of USD, fiscal years

Income statement, Unilever PLC, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Total revenue	59,316	54,332	65,779	64,290	59,618	61,949
Cost of revenue	31,469	28,964	37,996	38,427	34,399	35,032
Gross profit	27,846	25,368	27,783	25,864	25,220	26,917
Selling, general & administrative expenses	15,019	13,887	15,776	14,529	13,303	14,500
Research & development	982	923	1,047	972	963	977
Interest expense (income), operating	–	–	–	–	–	–
Unusual expense (income)	1,310	1,625	348	−972	1,135	1,275
Other operating expenses	1.2	0	0	0	0	0
Operating income	10,534	8,933	10,612	11,335	9,820	10,165
Net interest income (expense)	−467	−352	−427	−319	−81.8	−388
Gain (loss) on sale of assets	–	–	–	–	–	–
Other non-operating income (expense)	143	85.9	121	47.1	−11.4	−11.0
Net income before taxes	10,210	8,667	10,306	11,063	9,726	9,766
Provision for taxes	2,914	2,414	2,427	2,213	2,200	2,349
Minority interest	−637	−647	−721	−671	−650	−601
Equity in affiliates	–	–	–	–	–	–
U.S. GAAP adjustment	–	–	–	–	–	–
Net income before extraordinary items	6,659	5,605	7,159	8,179	6,877	6,816
Extraordinary items	4,461	342	–	–	–	–
Net income	11,120	5,947	7,159	8,179	6,877	6,816
EBIT, normalized	11,844	10,558	10,960	10,363	10,954	11,440
EBITDA, normalized	13,796	12,377	12,702	12,409	12,939	13,904
Basic EPS, normalized	3.47	3.63	3.16	3.04	3.48	–

Balance sheet in millions of USD, fiscal years

Balance sheet, Unilever PLC, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Assets
Cash & short-term investments	5,887	7,575	6,459	5,911	5,110	7,691
Receivables	7,406	6,086	6,275	6,922	5,973	5,874
Total inventory	4,748	5,360	5,649	6,347	5,324	5,449
Prepaid expenses	1,608	524	569	1,037	559	517
Other current assets	395	327	803	285	2,816	202
Total current assets	20,044	19,872	19,757	20,502	19,782	19,733
Property, plant & equipment	10,561	12,081	11,816	11,526	11,762	12,909
Goodwill	20,799	23,099	23,296	23,126	23,111	23,134
Intangibles	20,031	19,246	20,259	20,205	20,759	19,540
Long-term investments	3,563	1,653	1,551	1,270	1,371	1,121
Note receivable	355	356	435	557	567	568
Other long-term assets	7,415	6,258	5,951	6,098	8,016	5,628
Total assets	82,768	82,565	83,063	83,284	85,368	82,632
Liabilities
Accounts payable	12,912	10,620	11,428	11,879	10,113	10,228
Payable/accrued	–	–	–	–	–	–
Accrued expenses	6,124	5,806	6,146	6,269	5,543	5,700
Short-term debt	0	0	0	0	0	0
Current portion of long-term debt	2,886	6,421	5,409	5,962	8,027	5,234
Other current liabilities	3,520	3,278	2,960	3,101	4,485	3,986
Total current liabilities	25,442	26,125	25,942	27,212	28,168	25,149
Long-term debt	29,527	25,316	26,146	24,473	25,704	27,456
Minority interest	2,416	2,656	2,938	2,868	3,000	2,918
Other liabilities	7,143	7,773	8,060	8,374	9,049	8,465
Total liabilities	64,528	61,870	63,086	62,928	65,921	63,988
Shareholders' equity
Preferred stock	–	–	–	–	–	–
Common stock	99.8	91.1	97.1	98.5	105	112
Additional paid-in capital	62,065	54,710	58,318	56,554	60,073	89,731
Retained earnings (accumulated deficit)	−34,544	−25,075	−29,611	−25,291	−30,560	−62,283
Treasury stock	−4,469	−2,377	−6,888	−5,147	−3,872	−590
Other equity	−4,912	−6,653	−1,940	−5,858	−6,299	−8,327
Total equity	18,240	20,696	19,977	20,356	19,447	18,644
Total liabilities & shareholders' equity	82,768	82,565	83,063	83,284	85,368	82,632

Cash flow statement in millions of USD, fiscal years

Cash flow statement, Unilever PLC, fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Operating activities
Net income	7,297	6,594	7,880	8,850	7,527	7,417
Depreciation, depletion & amortization	1,589	1,819	1,743	2,083	2,004	2,465
Deferred taxes	–	–	–	–	–	–
Non-cash items	3,445	4,175	2,131	441	2,297	2,642
Changes in working capital	231	−2,733	−1,351	−3,580	−2,766	−1,461
Cash from operations	12,562	9,855	10,402	7,793	9,063	11,063
Investing activities
Capital expenditures	−1,869	−2,041	−1,926	−1,829	−1,523	−1,247
Other investing cash flows	−943	1,394	−606	4,454	−2,167	−562
Cash from investing	−2,812	−647	−2,532	2,625	−3,690	−1,809
Financing activities
Financing cash flow items	−2,493	−1,875	−1,574	−1,418	−1,123	−1,641
Cash dividends paid	−5,230	−4,471	−4,815	−4,633	−5,096	−5,226
Issuance (retirement) of debt, net	–	–	–	–	–	–
Other financing cash flows	−3,885	−840	−1,549	−3,463	−1,851	−221
Cash from financing	−11,609	−7,186	−7,938	−9,514	−8,070	−7,088
Foreign exchange effects	−585	−49.7	−131	−7.5	324	−506
Net change in cash	−2,443	1,972	−199	897	−2,374	1,660
Free cash flow	10,694	7,814	8,477	5,964	7,539	9,816

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.